Published in Cancer Weekly, August 14th, 1995
Researcher M.A. Jarvis and colleagues suggest that this direct DNA approach is more adaptable to the numerous human papillomavirus (HPV) types and avoids some of the problems experienced with recombinant protein vaccines.
Jarvis et al. presented their findings at the International Symposium on Clinical Immunology, held July 20-23 in San Francisco, California.
HPV is a family of over 79 distinct genotypes associated with a variety of clinical disorders including...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.